Abstract
We investigated the effects of coronary rotational atherectomy (PTCRA) on plasma levels of endothelin-1 (ET-1), atrial natriuretic peptide (ANP), and cyclic adenosine monophosphate (cAMP). We studied 14 patients undergoing PTCRA and compared them with 14 patients undergoing plain balloon angioplasty. Blood samples were taken from the femoral vein at baseline, after the end of the atherectomy, after the first balloon inflation, after the end of the procedure, and 4 hours later. ET-1 increased in the angioplasty group from 6.3 ± 3.2 pmol/L at baseline to 8.5 ± 3.9 pmol/L at the end of the procedure (F = 3.83, P = .02), whereas it did not change in the PTCRA group. ANP increased in the PTCRA group from 78.1 ± 15.7 pmol/L at baseline to 89.7 ± 24.0 pmol/L at the end of the procedure (F = 6.75, P = .0001), whereas it did not change in the angioplasty group. cAMP decreased in the PTCRA group, whereas it did not change in the angioplasty group. In conclusion, ET-1 increases less, ANP increases more, and cAMP decreases more during atherectomy than during plain balloon angioplasty.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baim DS, Carrozza JP. Understanding the “no-reflow” problem. Cath et Cardiovasc Diagn 1996;39:7-8.
Tahara A, Kohno M, Yanagi S, et al. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal angioplasty. Metabolism 1991;40:1235-1237.
Ameli S, Kaul S, Castro L, Arora C, Mirea A, Shah PK. Effect of percutaneous transluminal coronary angioplasty on circulating endothelin levels. Am J Cardiol 1993;72: 1352-1356.
Kyriakides ZS, Markianos M, Iliodromitis EK, Kremastinos DTh. Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischemia. Eur Heart J 1995;16:894-898.
Uehata A, Matsuguchi T, Bittl JA, et al. Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter. Circulation 1993;88:724-729.
Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-592.
Golino P, Piscione F, Benedict CR, et al. Local effect of serotonin released during coronary angioplasty. N Engl J Med 1994;330:523-528.
Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
Malatino LS, Grassi R, Stancanelli B, et al. Release of immunoreactive endothelin from the heart during percutaneous transluminal coronary angioplasty. Am Heart J 1993; 126:700-702.
Rubanyi GM, Vanhoutte PM. Hypoxia release a vasoconstrictor substance from the canine vascular endothelium. J Physiol 1985;364:45-56.
Williams MJ, Dow CJ, Newell JB, Palacios IF, Picard MH. Prevalence and timing of regional myocardial dysfunction after rotational coronary atherectomy. J Am Coll Cardiol 1996;28:861-869.
Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Cir C Res 1991;69:370-377.
Brunner F. Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and ischaemia and reperfusion. J Mol Cell Cardiol 1995;27:1953-1963.
Malatino LS, Leonardi C, Stancanelli B, et al. Transient myocardial ischemia stimulates atrial natriuretic factor release. Am Heart J 1992;123:693-698.
Herrmann HC, Rosenthal AD, Davis CA. Cardiovascular effects of intracoronary atrial natriuretic peptide administration in man. Am Heart J 1990;120:308-315.
Ball JH, Kaminsky NI, Hardman JG, Broadus AE, Sutherland EW, Liddle GW. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest 1972;51:2124-2128.
Kunitada S, Honma M, Ui M. Increases in plasma cyclic AMP dependent on endogenous catecholamines. Eur J Pharmacol 1978;48:159-169.
Kyriakides ZS, Bofilis E, Tousoulis D, Antoniadis A, Kremastinos DTh, Wedd DJ. EndothelinA receptor antagonist BQ-123 provokes vasodilation in the human epicardial coronary arteries. Fifth International Conference on Endothelin, Kyoto, Japan, 1997.
Brunner F, Toit EFD, Opie LH. Endothelin release during ischemia and reperfusion of isolated rat hearts. J Mol Cell Cardiol 1992;24:1291-1305.
Simonson MS, Dunn MJ. The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. J Lab Clin Med 1992;119:622-639.
Mitchell MD, Branch DW, Lamarche S, Dudley DJ. The regulation of endothelin production in human umbilical vein endothelial cells: Unique inhibitory action of calcium ionophores. J Clin Endocrinol Metab 1992;75:665-668.
Tonnessen T, Naess PA, Kirkeboen KA, Offstad J, Ilebekk A, Christensen G. Release of endothelin from the porcine heart after short term coronary artery occlusion. Cardiovasc Res 1993;27:1482-1485.
Ryan TJ, Vekshstein VI, Yeung AC, Bittl JA, Selwyn AP, Ganz P. The role of endothelin-1 in coronary vasoconstriction following balloon angioplasty (abstr). Eur Heart J 1991; 12:160.
Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 1993;12:667-672.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kyriakides, Z.S., Markianos, M., Antoniadis, A. et al. Effect of Rotational Coronary Atherectomy on Peripheral Endothelin-1, Atrial Natriuretic Peptide, and Cyclic Adenosine Monophosphate Plasma Levels. Cardiovasc Drugs Ther 12, 245–250 (1998). https://doi.org/10.1023/A:1007709614835
Issue Date:
DOI: https://doi.org/10.1023/A:1007709614835